naphthalimides has been researched along with Soft Tissue Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, X; Huang, ZS; Kang, S; Li, D; Li, X; Liu, B; Wang, J; Wei, Z; Zhang, M | 1 |
| Balcerzak, SP; Buys, SS; Metch, B; Neefe, JR; Stuckey, WJ | 1 |
1 trial(s) available for naphthalimides and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Phase II evaluation of amonafide in advanced sarcoma: a Southwest Oncology Group study.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Imides; Isoquinolines; Male; Middle Aged; Naphthalimides; Nausea; Organophosphonates; Sarcoma; Soft Tissue Neoplasms; Vomiting | 1994 |
1 other study(ies) available for naphthalimides and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Syntheses and evaluation of acridone-naphthalimide derivatives for regulating oncogene PDGFR-β expression.
Topics: Acridones; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Molecular Structure; Naphthalimides; Neoplasms, Experimental; Random Allocation; Receptor, Platelet-Derived Growth Factor beta; Soft Tissue Neoplasms | 2021 |